More indirect evidence of potential neuroprotective benefits of angiotensin receptor blockers

Journal of Hypertension

Volumn 28, Issue 3, 2010, Pages 429-

  Anderson, Craig ^a  

^a ROYAL PRINCE ALFRED HOSPITAL   (Australia)

Author keywords

[No Author keywords available]

Indexed keywords

ANGIOTENSIN RECEPTOR ANTAGONIST; DIPEPTIDYL CARBOXYPEPTIDASE INHIBITOR;

ANTIHYPERTENSIVE ACTIVITY; ARTERY COMPLIANCE; BLOOD PRESSURE REGULATION; BRAIN ISCHEMIA; CARDIOVASCULAR DISEASE; HIGH RISK POPULATION; HUMAN; HYPERTENSION; LIFESTYLE MODIFICATION; NERVE CELL LESION; NEUROPROTECTION; NOTE; OXIDATIVE STRESS; PRIORITY JOURNAL; RENIN ANGIOTENSIN ALDOSTERONE SYSTEM; STROKE;

EID: 77149180110     PISSN: 02636352     EISSN: None     Source Type: Journal    
DOI: 10.1097/HJH.0b013e3283371355     Document Type: Note

References (8)

1. Thone-Reineke C, Steckelings U, Unger T. Angiotensin receptor blockers and cerebral protection in stroke. J Hypertens 2006; 24:S115-S121.
2. Fuentes B, Fernández-Doḿinguez J, Ortega-Casarrubios MA, SanJosé B, Mart́inez-Sánchez P, D́iez-Tejedor E. Treatment with angiotensin receptor blockers (ARB) before stroke could exert a favourable effect in acute cerebral infarction. J Hypertens 2010; 28:575-581.
3. McCarthy C, Vinh A, Callaway JK, Widdop RE. Angiotensin AT2 receptor stimulation causes neuroprotection in a conscious rat model of stroke. Stroke 2009; 40:1482-1489.
4. Lei JM, Mogi M, Iwanami J, Min LJ, Tsukuda K, Sakata A, et al. Temporary pretreatment with the angiotensin II type 1 receptor blocker, valsartan, prevents ischemic brain damage through an increase in capillary density. Stroke 2008; 39:2029-2036.
5. The ONTARGET Investigators. Telmisartan, ramipril, or both in patients at high risk for vascular events. N Engl J Med 2008; 358:1547-1559.
6. The TRANSCEND Investigators. Effects of the angiotensin receptor blocker, telmisartan on cardiovascular events in high-risk patients intolerant to ACE-inhibitors: a randomized controlled trial. Lancet 2008; 372:1174-1183.
7. Ÿusuf S, Diener HC, Sacco RL, Cotton D, Ounpuu S, Lawton WA, et al., for the PRoFESS Study Group. Telmisartan to prevent recurrent stroke and cardiovascular events. N Engl J Med 2008; 359:1225-1237.
8. Turnbull F, Neal B, Ninomiya T, Algert C, Arima H, Barzi F, et al., on behalf of the Blood Pressure Lowering Treatment Trialists' Collaboration. Effects of different regimens to lower blood pressure on major cardiovascular events in older and younger adults: meta-analysis of randomised trials. BMJ 2008; 336:1121-1123.